AstraZeneca PLC aims for $80 billion revenue by 2030 through strong growth in oncology, biopharmaceuticals, and rare diseases ...

While Novo Nordisk and Lilly are the undisputed leaders in weight management right now, a number of pharmaceutical companies ...

AstraZeneca has become the latest big pharma company to devote new cash to its US manufacturing muscle this year as it ...

A new BLA for datopotamab deruxtecan aims for FDA accelerated approval to treat EGFR-mutated NSCLC based on data from ...

Bernstein analyst Justin Smith maintained a Buy rating on AstraZeneca (AZN – Research Report) today and set a price target of p18,000.00. Justin Smith has given his Buy rating due to a combination of ...

AstraZeneca Pharma India reported its financial results for Q2 FY25, showing a notable revenue increase. Revenue from ...

RSV symptoms include cough, fever, running nose, irritability, reduced activity, and pauses in breathing. Severe cases can ...

Indian Prime Minister Narendra Modi is set to receive Dominica's highest civilian award, the Dominica Award of Honour. The ...

AstraZeneca Pharma tumbled 5.12% to Rs 6,768 after the pharmaceutical firm's net profit declined 26.62% to Rs 38.43 crore in Q2 FY25 as compared with Rs 52.37 crore posted in Q2 FY24.

Astrazeneca has recently announced 3.5 billion dollars of capital investment in the United States focused on expanding the ...

AstraZeneca’s growth was driven by its portfolio of products in the oncology, biopharmaceuticals and rare disease segments ...

"Slingshot represents an opportunity to bridge the gap between academic innovation and clinical development of a novel ...